期刊文献+

男性乳房发育症的处理 预览 被引量:27

Treatment of gynecomastia
在线阅读 下载PDF
收藏 分享 导出
摘要 目的 探讨男性乳房发育症的病因、发病机制及最佳诊断和治疗方法。方法将本院自1999年1月至2008年12月门诊诊治和收住院的268例男性乳房发育症患者的l临床资料结合文献复习进行综合分析。计数资料的比较采用y。检验。结果生理性男性乳房发育240例,病理性男性乳房发育28例。后者根据其病因又分为:药物性男性乳房发育12例;肿瘤性男性乳房发育11例,其中肺癌4例,胃癌2例,肾上腺肿瘤2例,睾丸肿瘤2例,肾癌1例;其他5例,其中Klinefelter's综合征2例,甲状腺机能亢进和甲状腺机能低下各1例,尿毒症1例。随访结果:单纯临床观察组乳房发育完全消退率72.73%(56/77);药物治疗组的完全消退率达77.34%(99/128),疼痛缓解率达85.16%(109/128),其中他莫西芬组和乳癖散结胶囊组的完全消退率相似(x^2=0.289,P=0.591),且两组患者的疼痛缓解率亦相似,分别为84.12%(53/63)和86.15%(56/65)。结论多数男性乳房发育属生理性,可予以临床观察,中药(乳癖散结胶囊)不仅可以改善患者的乳房疼痛或触痛等症状,还可提高其完全消退率,且无明显不良反应。 Objective To explore the pathologic causes,pathogenesis,and a optimal diagnostic and treatment method for gynecomastia. Methods From January 1999 to December 2008, 268 patients with gynecomastia were treated in our hospital. Their data were analyzed comprehensively combined with document review. Chi-square test was used for the analysis of numeration data. Results Among the 268 patients, 240 had physiological gynecomastia, and 28 had pathological gynecomastia. Aeording to the pathologic causes, of the 28 pathological gynecomastia patients, 12 had drug-induced gynecomastia, 11 had tumor-induced gynecomastia (lung cancer in 4, gastric cancer in 2, adrenal neoplasm in 2, testicular tumor in 2, and renal-cell carcinoma in 1), and 5 patients were induced by other causes including Klinefelter's syndrome in 2, thyrotoxicosis in 1, hypothyreosis in 1 and uremia in 1. The results of follow-up showed the rate of complete regression of gynecomastia was 72. 73% (56/77)in the clinical observation group, and 77. 34 (99/128)in drug treatment group. The curative effect had no significant difference between the tamoxifen group and the Rupisanjiejiaonang group (x^2 = 0. 289, P= 0. 591), the rate of breast pain relief was 85.16%(109/128) and similar in the two groups, 84.12%(53/63) in the tamoxifin group and 86. 15% (56/65) in the Rupisanjiejiaonang group,respectively. Conclusion Most gynecomastia cases are physiological and do not need treatment. Chinese medical therapy (Rupisanjiejiaonang) not only improves breast pain and tenderness but also increases the rate of complete regression, moreover, the curative effect is not statistically different between Rupisanjiejiaonang and tamoxifen, and Rupisanjiejiaonang has no obvious side-effects.
作者 辛智芳 XIN Zhi fang.( Breast Center, Linyi Tumour Hospital, Linyi 276001 , China)
出处 《中华乳腺病杂志(电子版)》 CAS 2009年第4期 29-33,共5页 Chinese Journal of Breast Disease (Electronic Version)
关键词 男子乳腺发育 病因 分类 诊断 治疗 Gynecomastia Etiopathogenisis Classification Diagnosis Treatment
  • 相关文献

参考文献18

  • 1Braunstein G D. Clinical practice. Gynecomastia. N Engl J Med,2007, 2,57:1229-1237. 被引量:1
  • 2Georgiadis E, Papandreou L, Evangelopoulou C, et al. Incidence of gynecomastia in 9,54 young males and its relationship to somatometric parameters. Ann Hum Biol, 1994,21:579--587. 被引量:1
  • 3孙子渊,叶林译.男性乳房发育的处理//王永胜,于金明,叶林译.乳腺病学.3版.济南:山东科学技术出版社,2006:67-74. 被引量:1
  • 4周正波,王永胜,左文述.男性乳房发育症与男性乳腺癌//左文述.现代乳腺肿瘤学,2版.济南:山东科学技术出版社,2006:1324-1338. 被引量:1
  • 5Harman S M, Metter E J, Tobin J D, et al. Longitudinal effects of aging on serum total and free testosterone levels in healthy men. J Clin Endocrinol Metab, 2001,86 :724 -- 731. 被引量:1
  • 6Mathur R, Braunstein G D. Gynecomastia: pathomechanisms and treatment strategies. Horm Res, 1997,48 : 95-- 102. 被引量:1
  • 7Braunstein G D. Aromatase and gynecomastia. Endocr Relat Cancer, 1999,6:315-- 324. 被引量:1
  • 8李瑞珍,夏治,林汉华,温宇,吴静,王宏伟.男性儿童乳房发育症240例临床分析[J].中国当代儿科杂志,2007,9(5):404-406. 被引量:4
  • 9Andersen J A, Gram J B. Gynecomasty: histological aspects in a surgical material. Acta Pathol Microbiol Immunol Scand, 1982,90 : 185-- 190. 被引量:1
  • 10Thompson D F, Carter J R. Drug induced gynecomastia. Pharmacotherapy, 1993,13 : 37--45. 被引量:1

二级参考文献22

  • 1孙家明 ,乔群 ,张海林 ,孙宝东 ,闫迎军 .女性乳房的血管构筑研究及其临床意义[J].中国临床解剖学杂志,2004,22(4):337-339. 被引量:18
  • 2姜军,杨新华,范林军,张毅,张帆,周艳.腔镜手术在乳腺疾病外科治疗中的应用[J].中华医学杂志,2005,85(3):181-183. 被引量:59
  • 3[1]Kompatscher P.Endoscopic capsulotomy of capsular contracture after breast augmentation:a very challenging therapeutic approach.Plast Reconstr Surg,1992,90:1125-1126. 被引量:1
  • 4[2]Simon B E,Hoffman S,Kahn S.Classification and surgical correction of gynecomastia.Plast Reconstr Surg,1973,51:48-52. 被引量:1
  • 5[5]Kitamura K,Ishida M,Inoue H,et al.Early results of an endoscope-assisted subcutaneous mastectomy and reconstruction for breast cancer.Surgery,2002,131:S324-S329. 被引量:1
  • 6[7]Carlson G W,Bostwick J,Styblo T N,et al.Skin sparing mastectomy,oncologic and reconstructive considerations.Ann Surg,1997,225:570-578. 被引量:1
  • 7[8]Colombo Benkmann M,Buse B,Stern J,et al.Indications for and results of surgical therapy for male gynecomastia.Am J Surg,1999,178:60-63. 被引量:1
  • 8[9]Courtiss E H.Gynecomastia:Analysis of 159 patients and current recommendations for treatment.Plast Reconstr Surg,1987,79:740-753. 被引量:1
  • 9[10]Esme D L,Beekman W H,Hage J J,et al.Combined use of ultrasonic-assisted liposuction and semicircular periareolar incision for the treatment of gynecomastia.Ann Plast Surg,2007,59:629-634. 被引量:1
  • 10[11]Yavuz M,Kesiktas E,Kesiktas N N,et al.Lighted retractor-assisted transaxillary approach in gynecomastia correction.Ann Plast Surg,2006,57:370-373. 被引量:1

共引文献26

同被引文献222

引证文献27

二级引证文献66

投稿分析

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部 意见反馈
新型冠状病毒肺炎防控与诊疗专栏